Daiwa Securities Group’s UroGen Pharma URGN Stock Holding History

Daiwa Securities Group’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-160	Closed	-$4K	–	1437
2025 Q4	$4K	Hold	160	–	–	﹤0.01%	1260
2025 Q3	$3K	Hold	160	–	–	﹤0.01%	1254
2025 Q2	$2K	Hold	160	–	–	﹤0.01%	1234
2025 Q1	$2K	Hold	160	–	–	﹤0.01%	1202
2024 Q4	$2K	Hold	160	–	–	﹤0.01%	1236
2024 Q3	$2K	Buy	160 +112	+233%	+$1.66K	﹤0.01%	1237
2024 Q2	$1K	Hold	48	–	–	﹤0.01%	1302
2024 Q1	$1K	Hold	48	–	–	﹤0.01%	1307
2023 Q4	$1K	Hold	48	–	–	﹤0.01%	1310
2023 Q3	$1K	Hold	48	–	–	﹤0.01%	1279
2023 Q2	$0	Hold	48	–	–	﹤0.01%	1350
2023 Q1	$0	Hold	48	–	–	﹤0.01%	1323
2022 Q4	$0	Hold	48	–	–	﹤0.01%	1392
2022 Q3	$0	Hold	48	–	–	﹤0.01%	1402
2022 Q2	$0	Hold	48	–	–	﹤0.01%	1431
2022 Q1	$0	Hold	48	–	–	﹤0.01%	1421
2021 Q4	$0	Hold	48	–	–	﹤0.01%	1447
2021 Q3	$1K	Hold	48	–	–	﹤0.01%	1287
2021 Q2	$1K	Hold	48	–	–	﹤0.01%	1218
2021 Q1	$1K	Hold	48	–	–	﹤0.01%	1229
2020 Q4	$1K	Sell	48 -70	-59%	-$1.47K	﹤0.01%	1208
2020 Q3	$2K	Hold	118	–	–	﹤0.01%	1146
2020 Q2	$32K	Hold	118	–	–	﹤0.01%	981
2020 Q1	$2K	Hold	118	–	–	﹤0.01%	1167
2019 Q4	$3K	Sell	118 -15	-11%	-$409	﹤0.01%	1149
2019 Q3	$3K	Sell	133 -17	-11%	-$556	﹤0.01%	1109
2019 Q2	$5K	Hold	150	–	–	﹤0.01%	1105
2019 Q1	$6K	Buy	+150	New	+$6.29K	﹤0.01%	1071

Other funds holding URGN

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Daiwa Securities Group's URGN Position: Q1 2026 in Review

Daiwa Securities Group sold out of UroGen Pharma (URGN) in Q1 2026, closing a stake of 160 shares — an estimated $4K sold.

Daiwa Securities Group first reported a position in URGN in Q1 2019 and held it in 28 quarters. The position peaked at $32K in Q2 2020. 173 funds tracked by Wall St. Rank hold URGN as of Q1 2026.

Daiwa Securities Group reported no remaining UroGen Pharma position as of Q1 2026 after selling out during the quarter.
Daiwa Securities Group sold 160 UroGen Pharma shares in Q1 2026, an estimated $4K.
Daiwa Securities Group first reported a position in UroGen Pharma in Q1 2019 and held it in 28 quarters.
Daiwa Securities Group's UroGen Pharma position peaked at $32K in Q2 2020.
173 funds tracked by Wall St. Rank held UroGen Pharma as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.